Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma - Wikidata - wikimedia - TriplyDB

Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma

Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma

http://www.wikidata.org/entity/Q35232507

about

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysis Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression MGMT promoter methylation correlates with an overall survival benefit in Chinese high-grade glioblastoma patients treated with radiotherapy and alkylating agent-based chemotherapy: a single-institution study.A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas.Differential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.MGMT testing allows for personalised therapy in the temozolomide era.The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma.Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy.Double-labelling immunohistochemistry for MGMT and a "cocktail" of non-tumourous elements is a reliable, quick and easy technique for inferring methylation status in glioblastomas and other primary brain tumours.Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene.MGMT testing for glioma in clinical laboratories: discordance with methylation analyses prevents the implementation of routine immunohistochemistry.Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.Aberrant Kynurenine Signaling Modulates DNA Replication Stress Factors and Promotes Genomic Instability in Gliomas.DNA methylation, histone modifications, and signal transduction pathways: a close relationship in malignant gliomas pathophysiology.Molecular and genetic aspects of oncology and infectology in Clinics.Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma.Prognosis of glioblastoma with faint MGMT methylation-specific PCR product.Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma.MGMT promoter methylation in Peruvian patients with glioblastoma.Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma.An intronic genetic variation of affects enhancer activity and is associated with glioma susceptibility Epigenetic Targeting of Glioblastoma

P2860

Q26795767-454D51CD-A05C-4B35-AF04-049DB85DEF88 Q28074595-47BBBCE3-18AC-4EAD-8589-CAF56F2319A5 Q28550138-E7B7A48D-418A-48B7-9107-D41F1292D002 Q34166477-9F1FDDD6-FE93-4E03-9EE3-9E41B904B77B Q34427825-0623551E-A5BE-448F-8263-41E7397463E8 Q34684614-B6366777-FE01-4A75-BBE4-853FE57FE452 Q35673519-C04E4D31-A2A6-4A74-883B-73B2E6E3BEBF Q35827916-938F2F34-D2D2-40B0-88CA-B926D9C5BC57 Q35992345-A75D5AAA-D5AC-4E2F-B6F7-7FAA2A7E741D Q36500074-E27A19BE-1A0C-4482-8B2B-3DC69D9D78B5 Q36552798-5EC94F2B-C120-4A20-9BC8-7CBEB6BB7FB5 Q37485637-6210D4D9-6E46-4493-8319-A2324BEB5BA5 Q37502558-7333411C-63D9-4CC0-B096-EE2359B5245B Q38044236-8591E5B8-D9F0-48AE-AAC7-D074CC9D5BC3 Q38101368-2C1098CA-18BE-4128-BF28-0E9417EF16DA Q38675705-F214539E-0C29-4C3A-BE3B-CC3BC6476F00 Q38736662-61CE5B74-881A-4159-BC8D-DE6653E0AAEF Q40216898-C3C03E24-14C9-4AB1-809E-14B2E70954A6 Q41720039-7EC42FC7-5E68-4BCC-A2A9-2941E8C2F30F Q42090451-E173107F-729A-465A-A692-7B679BB7EBB9 Q42410325-CB887D20-D26A-4738-8D52-0B0F28D5E15A Q48024213-6F5C0532-5828-4B85-9ECE-A73A26729349 Q48137109-24A7D6DE-FF57-4096-B49B-6F64ABD85164 Q53739720-FF14A5D5-0D24-4534-B51A-E9B3DBAD0C31 Q55139727-B2A1CE3F-82DD-440C-9A10-2D073695BD50 Q55140281-36A61E95-42AC-4DAD-8713-501126725093 Q55451515-0171F700-78F1-4442-8D02-368982D7C460 Q57490699-ECEF7A35-AA43-4082-B96B-0061AE5CE23B Q58554073-CA006DE1-7CF9-454B-8839-61518BCD01FB

P2860

Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma

http://www.wikidata.org/entity/Q35232507

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Correlation of MGMT promoter m ...... ression levels in glioblastoma

@ast

Correlation of MGMT promoter m ...... ression levels in glioblastoma

@en

type

label

Correlation of MGMT promoter m ...... ression levels in glioblastoma

@ast

Correlation of MGMT promoter m ...... ression levels in glioblastoma

@en

prefLabel

Correlation of MGMT promoter m ...... ression levels in glioblastoma

@ast

Correlation of MGMT promoter m ...... ression levels in glioblastoma

@en

P1433

Q35232507-4C85EEF1-6A3F-4308-A9F7-C4D9AAF9E02D

P1476

Q35232507-5B78C888-FBE8-45B8-9B4F-AF0E1507EB65

P2093

Q35232507-0972419B-CC1C-4245-9D5C-3A181DC801CB

Q35232507-29127E51-AB4E-41AC-9036-F50442E9140C

Q35232507-32AE68F7-D5C4-4A01-84D4-CC3E980B6CEA

Q35232507-730AF83B-5437-4F97-B0AB-CC0C4DDD461A

Q35232507-8977EA7C-A260-4FA0-B4FD-75445D6ED94C

Q35232507-DFD0CA6F-EF41-4283-9E88-3E80CF5E2C60

Q35232507-E3E9588F-1D8B-48B1-B712-2EB5255B5D97

Q35232507-F69F783E-F818-4FC0-ABFB-F819672F6926

Q35232507-FFC58848-7C85-436F-A026-870807BDE820

P2860

Q35232507-00BBB65A-8CEF-4730-B2D4-4BAD8E015D45

Q35232507-14C77885-2D98-4E16-A796-EAAE89BFF0E5

Q35232507-1874E0CC-48A5-4A9A-9733-1501BFF91E79

Q35232507-1C930BAC-61E2-49DE-9C76-DEC89DA9AF35

Q35232507-238CF9AB-2B3F-4B26-9530-B91D70E59F5C

Q35232507-295E755E-C2A0-4D6A-B5F8-774A18E05299

Q35232507-2C8257B5-3C14-4051-8980-8BC5F14755E6

Q35232507-2F0B7ED4-C666-44BC-B01E-D7ECEF84D662

Q35232507-3C0B22C4-07E4-4CE4-91BF-513F441A4DC8

Q35232507-44864D6D-E6C0-48A0-A74F-11165F1F723E

P304

Q35232507-6AF80F10-F8BD-4F23-A454-9F41A520EA24

P31

Q35232507-1937EB78-D66D-40DE-9046-F4779845D3D1

P356

Q35232507-5C2FEA6F-E8FC-40CD-B109-9CE96193341B

P433

Q35232507-441CA3BF-4447-477E-8653-9446CCF67AC5

P478

Q35232507-4954A947-9B02-4DE4-B309-0086CB350346

P50

Q35232507-61C26DDA-E70D-4BF6-B3BC-1F464CEB51EF

P577

Q35232507-EC27E0CC-0F7D-46B3-9A7C-38FCCBB2804D

P698

Q35232507-3C4B2D28-B86D-45D2-91B7-511A0A61723E

P932

Q35232507-E1CD89DA-A999-471D-B139-D0E7753263FE

P356

S1807-59322011001000013

P1433

P1476

Correlation of MGMT promoter m ...... ression levels in glioblastoma

@en

P2093

Anamaria Aranha Camargo

http://www.w3.org/2001/XMLSchema#string

Hector Navarro Cabrera

http://www.w3.org/2001/XMLSchema#string

Manoel Jacobsen Teixeira

http://www.w3.org/2001/XMLSchema#string

Marcos Begnami

http://www.w3.org/2001/XMLSchema#string

Miyuki Uno

http://www.w3.org/2001/XMLSchema#string

Paulo Henrique de Aguiar

http://www.w3.org/2001/XMLSchema#string

Ricardo Pereira Moura

http://www.w3.org/2001/XMLSchema#string

Sueli Mieko Oba-Shinjo

http://www.w3.org/2001/XMLSchema#string

Sérgio Rosemberg

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites

Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing

Epidemiology of primary brain tumors: current concepts and review of the literature.

The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression.

Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR

Xenograft transplantation of human malignant astrocytoma cells into immunodeficient rats: an experimental model of glioblastoma.

P304

1747-1755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S1807-59322011001000013

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22012047

http://www.w3.org/2001/XMLSchema#string

P932

3180167

http://www.w3.org/2001/XMLSchema#string